Remove 2008 Remove Communication Remove Compounding
article thumbnail

Employee Spotlight: Paula Styer Pharmacy Technician

indispensable health

I have been a pharmacy technician since 2008. It has been since 2008 so it’s been good for me. Paula : I do, primarily I am a compounder, that is how I started out. I am manipulating something for an end product and that’s what I like about compounding - the end product, and [the process of] coming to it. I love reading.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. Compounding Pharmacies: Who Is in Charge?”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Brain Fog and Hashimoto’s

The Thyroid Pharmacist

Compounded medications : If NDT medications do not seem like a good fit for you, compounded T4/T3 products offer another alternative. Thyroid compounds are usually prepared in the same physiological ratio that is found in NDT products. 2008 Aug 7; 149(1-3): 11–14. [16] 24 Sep 2008. Ann Gastroenterol. 15] Banks WA.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

63] Many of the benefits of ginger are due to gingerol and shogaol, compounds called gingeroids, which may also help with bloating, belching, and discomfort after meals. [64] 82] Many of them do so by helping the gut to communicate with the central nervous system, essentially retraining it to move more efficiently. 2000;46(4):493-499.

article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

From a regulatory perspective, the only products that are to be excluded are sensitizing agents, including penicillins and cephalosporins (beta-lactams); potentially genotoxic compounds; and potentially OEB 5 compounds where the risk assessment indicates the compound cannot be adequately controlled. Published 2008.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment. Leave this field blank